Clinical data | |
---|---|
Routes of administration |
By mouth |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Biological half-life | 34–38 hours |
Identifiers | |
|
|
CAS Number | |
PubChem CID | |
ChemSpider | |
KEGG | |
ChEBI | |
ChEMBL | |
ECHA InfoCard | 100.005.563 |
Chemical and physical data | |
Formula | C23H29ClO4 |
Molar mass | 404.92696 g/mol |
3D model (Jmol) | |
|
|
|
Chlormadinone acetate (abbreviated as CMA) (INN, USAN, BAN, JAN) (sold under brand names including Clordion, Gestafortin, Lormin, Non-Ovlon, Normenon, Verton, and many others), and also known as 17α-acetoxy-6-chloro-6-dehydroprogesterone, is a steroidal progestin with additional antiandrogen and antigonadotropic (and by extension antiestrogenic) effects. CMA has been used in the treatment of vaginal bleeding, oligomenorrhea, polymenorrhea, hypermenorrhea, secondary amenorrhea, and endometriosis. It has also been used clinically as a hormonal contraceptive, and in part due to its capacity to lower estrogen levels, but also for improved effectiveness in contraception, chlormadinone has frequently been combined with ethinylestradiol for this purpose.
CMA is the acetate ester of chlormadinone, which, in contrast to CMA, was never marketed.
CMA acts predominantly as a potent progestogen, but also as an antiandrogen. Due to its potent actions as a progestogen, CMA also has strong antigonadotropic properties, and thus additional antiandrogen as well as antiestrogen properties.